Gerresheimer AG's EBIT per Share for the
three
months ended in Aug. 2025 was CHF0.23.
Its EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2025 was CHF3.88.
During the past 12 months, the average EBIT per Share Growth Rate of Gerresheimer AG was -22.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 3.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 32.40% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 3.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Gerresheimer AG's EBIT per Share or its related term are showing as below:
XSWX:GXI'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -43.4 Med: 9.65 Max: 80
Current: 3.9
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Gerresheimer AG was 80.00% per year. The lowest was -43.40% per year. And the median was 9.65% per year.
XSWX:GXI's 3-Year EBIT Growth Rate is ranked worse than 57.74% of 691
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs XSWX:GXI: 3.90
Gerresheimer AG's EBIT for the
three
months ended in Aug. 2025 was CHF8 Mil.
Gerresheimer AG (XSWX:GXI) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Gerresheimer AG EBIT per Share Related Terms
Gerresheimer AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF3.88
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (XSWX:GXI) has a EBIT per Share of CHF3.88 as of Aug. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Gerresheimer AG and its competitors. According to the industry distribution chart, Gerresheimer AG ranks #399 out of 691 companies in the Medical Devices & Instruments industry, placing it in the top 57.7%.
Is Gerresheimer AG's EBIT per Share too high?
Gerresheimer AG's current EBIT per Share is CHF3.88. Based on the distribution chart, Gerresheimer AG ranks #399 out of 691 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Gerresheimer AG has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #399 out of 691 companies for EBIT per Share. This places Gerresheimer AG in the lower half of its industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 691 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current EBIT per Share is CHF3.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (XSWX:GXI) is currently considered Possible Value Trap. The stock's GF Value™ is CHF87.96, compared to a current price of CHF25.02 — trading 71.6% below its estimated fair value. The current EBIT per Share is CHF3.88. Gerresheimer AG's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current EBIT per Share is CHF3.88 as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of CHF25.02 is trading 71.6% below its estimated GF Value™ of CHF87.96.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for XSWX:GXI:
EBIT per Share: CHF3.88
GF Value™: CHF87.96 vs. price of CHF25.02 (71.6% below fair value)
No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
73GF Score
Get the complete analysis for XSWX:GXI
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GXI has been successfully added to your 
